Results 141 to 150 of about 100,532,293 (204)

Rhodobacter capsulatus PG Lipopolysaccharide As a Potential Blocker of Toll-like Receptor 2 and 4 Activation. [PDF]

Acta Naturae
Zubova SV, Radzyukevich YV, Kosyakova NI, Prokhorenko IR.   +3 more
europepmc   +1 more source

Correction: Pre-activation of toll-like receptor 2 enhances CD8+ T-cell responses and accelerates hepatitis B virus clearance in the mouse models. [PDF]

Front Immunol
Lin Y, Huang X, Wu J, Liu J, Chen M, Ma Z, Zhang E, Liu Y, Huang S, Li Q, Zhang X, Hou J, Yang D, Lu M, Xu Y.   +14 more
europepmc   +1 more source

Mono-Palmitoyl-N-Alkylurea Ligands as Specific Activators of Human Toll-Like Receptor 2/6 Heterodimer. [PDF]

Chembiochem
Isendoorn MME, Castello G, Koç Ç, Meeuwenoord N, Codée JDC, Ossendorp F, Filippov DV.   +6 more
europepmc   +1 more source

Fucosylated Glycosaminoglycan Oligosaccharide HS14, Derived from Sea Cucumbers, Is a Novel Inhibitor of Platelet Toll-like Receptor 2. [PDF]

Mar Drugs
Sun H, Zhu G, Li S, Li P, Zhang J, Yin R, Yuan L, Gao N, Zhao J.   +8 more
europepmc   +1 more source

Atomic-level binding interaction analysis of <i>Mycobacterium tuberculosis</i> membrane protein Rv1085c with Toll-Like receptor 2 to investigate its role in immune response. [PDF]

In Silico Pharmacol
Radhakrishnan L, Navabshan I, Lavanya V, Jamal S, Ahmed N.   +4 more
europepmc   +1 more source

Toll-like receptor 2/6-stimulated HMC-1 mast cells promote keratinocyte migration in wound healing. [PDF]

PLoS One
Kwon J, Cho KA, Woo SY.
europepmc   +1 more source

Astrocytes contribute to toll-like receptor 2-mediated neurodegeneration and alpha-synuclein pathology in a human midbrain Parkinson's model. [PDF]

Transl Neurodegener
Weiss F, Hughes L, Fu Y, Bardy C, Halliday GM, Dzamko N.   +5 more
europepmc   +1 more source

Activation of toll-like receptor 2 promotes the expression of inflammatory mediators and cell proliferation of human polycystic kidney disease cells. [PDF]

Cell Signal
Zhang Y, Plansinis M, Peak S, Weber E, Wei A, Xu Y, Ross M, Leagjeld A, Wallace DP, Zhang Y.   +9 more
europepmc   +1 more source

Lipoprotein <i>N</i>-terminal modification in <i>Bacillus</i>: a new paradigm for extracellular acetylation and species-dependent Toll-like receptor 2 immunomodulation. [PDF]

mBio
Komazin G, Wigmore RM, Ranade AM, Rizk AA, Gardiner JH, Meredith TC.   +5 more
europepmc   +1 more source